Integra Lifesciences Holdings Corp (IART) financials
Integra Lifesciences Holdings revenue and earnings by year
Integra Lifesciences Holdings's revenue was $1.64 billion in the fiscal year to December 31, 2025, up 1.5% from the year before. Net income was -$516 million, -31.6% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 5.7% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.64 | 1.61 | 1.54 | 1.56 | 1.54 | 1.37 | 1.52 | 1.47 | 1.19 | 0.99 |
| Revenue growth | 1.5% | 4.5% | -1.0% | 1.0% | 12.4% | -9.6% | 3.1% | 23.9% | 19.8% | — |
| Gross profit | 0.83 | 0.88 | 0.88 | 0.97 | 0.94 | 0.85 | 0.95 | 0.90 | 0.75 | 0.64 |
| Gross margin | 50.9% | 54.8% | 57.4% | 62.3% | 61.2% | 62.0% | 62.8% | 61.2% | 63.3% | 64.8% |
| Operating income | -0.49 | 0.03 | 0.11 | 0.24 | 0.20 | 0.15 | 0.09 | 0.11 | 0.04 | 0.12 |
| Operating margin | -30.2% | 1.8% | 7.2% | 15.3% | 12.8% | 11.0% | 6.2% | 7.5% | 3.8% | 11.6% |
| Net income | -0.52 | -0.01 | 0.07 | 0.18 | 0.17 | 0.13 | 0.05 | 0.06 | 0.06 | 0.07 |
| Net margin | -31.6% | -0.4% | 4.4% | 11.6% | 11.0% | 9.8% | 3.3% | 4.1% | 5.4% | 7.5% |
| Diluted EPS | -$6.74 | -$0.09 | $0.84 | $2.16 | $1.98 | $1.58 | $0.58 | $0.72 | $0.82 | $0.94 |
| Free cash flow | -0.03 | 0.02 | 0.07 | 0.23 | 0.26 | 0.17 | 0.16 | 0.12 | 0.07 | 0.07 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open IART in Markets.
How Integra Lifesciences Holdings makes money
Revenue by segment in the quarter to September 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Specialty Surgery | $304M | 74.0% |
| Tissue Reconstruction | $107M | 26.0% |
See also: IART valuation and P/E history · IART returns
No forecast, no recommendation. This page describes Integra Lifesciences Holdings Corp from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.